Search results for: 'research area tyrosine kinase fak'
-
L1051 DiscoveryProbe™ Human Endogenous Metabolite Compound LibrarySummary: A collection of 548 Human Endogenous Metabolite Compound supplied as lyophilized powder or pre-dissolved DMSO solutions
-
A3351 Dasatinib hydrochlorideSummary: Multi-BCR/Abl and Src kinase inhibitor, oral active
-
B2287 LY3649471 CitationSummary: inhibitor of TGF-β type I receptor kinase domain
-
B6066 Bisindolylmaleimide VSummary: negative control for protein kinase C (PKC)-inhibitory activity
-
C3340 3MB-PP1Summary: polo-like kinase 1 (Plk1) allele inhibitor,ATP-competitive
-
C3984 Hemin chlorideSummary: eukaryotic translation initiation factor 2α kinase 1 (eIF2αK1) inhibitor
-
B4969 KN-93 PhosphateTarget: Ca2 /calmodulin-dependent protein kinases (CaMKs)Summary: CaM kinase II inhibitor, water soluble and cell permeable
-
B5946 EW-71971 CitationTarget: BMP and Other Activin ReceptorsSummary: Selective inhibitor of TGF-β type I receptor kinase
-
B5130 JIP-1 (153-163)Summary: Peptide inhibitor of c-Jun N-terminal kinase (JNK)
-
B5174 PKC β pseudosubstrateSummary: Selective cell-permeable peptide inhibitor of protein kinase C